Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Renal Insufficiency × Data Collection × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 13 Pancreatic Neoplasms 5 Breast Neoplasms 5 Ovarian Neoplasms 3 Multiple Myeloma 3 Lymphoma 3 Uterine Cervical Neoplasms 2 Thyroid Diseases 2 Prostatic Neoplasms 2 Pancreatic Cyst 2 Neoplasm Metastasis 2 Myasthenia Gravis 2 Mesothelioma, Malignant 2 Melanoma 2 Lymphoma, Non-Hodgkin 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Hairy Cell 2 Leukemia 2 Hematologic Neoplasms 2 Endometrial Neoplasms 2 Wilms Tumor 1 Venous Thrombosis 1 Venous Thromboembolism 1 Uveal Melanoma 1 Thyroid Nodule 1 Thyroid Neoplasms 1 Thrombosis 1 Testicular Neoplasms 1 Testicular Germ Cell Tumor 1 Stomach Neoplasms 1

Interventions

Dexamethasone 8 Bortezomib 7 Cyclophosphamide 6 Lenalidomide 4 isatuximab 3 Calcium Dobesilate 3 glucarpidase 2 Thalidomide 2 Kidney Transplantation 2 Blood Specimen Collection 2 Bendamustine Hydrochloride 2 pomalidomide 1 gamma-Glutamyl Hydrolase 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 daratumumab 1 auricularum 1 Whole-Body Irradiation 1 Urination 1 Stents 1 Standard of Care 1 Rituximab 1 Ranitidine 1 Nephrotomy 1 Nephrostomy, Percutaneous 1 Methotrexate 1 Leucovorin 1 Ice 1 Health Information Exchange 1 Eplerenone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03234335 2023-05-06

IRMYG

Centre Hospitalier Universitaire de Saint Etienne

Multiple Myeloma, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡